|1.||Ikeda, Ryuji: 10 articles (09/2013 - 03/2002)|
|2.||Furukawa, Tatsuhiko: 9 articles (09/2013 - 03/2002)|
|3.||Sivridis, E: 9 articles (04/2010 - 01/2000)|
|4.||Karumanchi, S Ananth: 8 articles (04/2015 - 02/2004)|
|5.||Yamada, Katsushi: 8 articles (09/2013 - 03/2002)|
|6.||Koukourakis, M I: 8 articles (04/2010 - 01/2000)|
|7.||Giatromanolaki, A: 8 articles (04/2010 - 01/2000)|
|8.||Yoshiji, Hitoshi: 8 articles (01/2010 - 03/2002)|
|9.||Harris, A L: 8 articles (09/2006 - 01/2000)|
|10.||Ikenaka, Yasuhide: 7 articles (01/2010 - 12/2003)|
04/30/2009 - "We conclude that in mice hVEGF-D is an angiogenic factor associated with improved muscle regeneration after ischemic injury but also with increased incidence of tumor formation with a preference for mammary gland tumors."
01/01/2014 - "Study outcomes included cancer cell proliferation rates and angiogenic factor secretion from cancer cells. "
10/01/2007 - "In this study, we further investigated the role of MEKK3 in embryonic angiogenesis, tumor angiogenesis, and angiogenic factor production. "
01/15/2004 - "The purpose of this study is to develop a high-throughput approach to detect protein expression from hundreds and thousands of samples and to apply this technology to profile circulating angiogenic factor protein levels in patients with gynecological tumors. "
02/01/2003 - "The potential role of angiogenesis stimulators in the pathogenesis of different tumor entities has been confirmed in several studies. "
01/01/2012 - "In this study, we assessed the potential of a new angiogenic factor AGGF1 for therapeutic angiogenesis in a critical limb ischemia model in mice for PAD. "
01/01/2012 - "Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model."
06/01/2010 - "Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia."
09/01/2007 - "It has feasibility for using the HIF-1-HRE system for regulation of angiogenic factor expression in ischemia heart."
07/01/2007 - "The use angiogenesis stimulators for the treatment of chronic ischemia of lower extremities."
|3.||Breast Neoplasms (Breast Cancer)
07/01/2009 - "During pregnancy, there was a general increase in each angiogenic factor, but degree of increase from one sampling period to the next was not associated with later breast cancer risk. "
02/01/2007 - "Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer."
03/01/2006 - "Here, we show that ectopic PAR1 expression induces expression of the angiogenic factor Cyr61(CCN1) in breast cancer cells. "
06/01/2003 - "The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives."
01/10/1998 - "It acts as an angiogenesis factor in breast cancer, but paradoxically inhibits proliferation in several breast cancer cell lines. "
|4.||Urinary Bladder Neoplasms (Bladder Cancer)
11/01/2001 - "Angiogenesis, angiogenic factor expression and prognosis of bladder cancer."
07/01/1993 - "The purified substance was named bladder cancer angiogenic factor (BCAF). "
07/01/1993 - "An angiogenic factor from human transitional cell cancer of bladder has been purified by protein extraction, cation exchange chromatography, gel filtration high-performance liquid chromatography (GE-HPLC) and reversed-phase high-performance liquid chromatography (RP-HPLC). "
07/01/1993 - "An angiogenic factor from human bladder cancer: the investigation of purification and biological activities."
06/01/1993 - "The purified substance was named as bladder cancer angiogenic factor (BCAF). "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|4.||Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
|8.||O-(chloroacetylcarbamoyl)fumagillol (TNP 470)
|2.||Heterologous Transplantation (Xenotransplantation)
|4.||Drug Therapy (Chemotherapy)
|5.||Transplantation (Transplant Recipients)